- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
- Max Capital is pleased to announce that Brian Mok, P. Eng., has joined the Toronto based firm as Sr. Vice President and Mining Analyst.
"Brian brings over ten years of direct mining industry experience to the company and an excellent track record of providing equity research analysis," said Scott Walters, Managing Partner of Max Capital Markets Ltd. "The addition of Brian Mok, with his extensive market experience, will enable Max Capital to provide clients with a broader and deeper understanding of the resource sector," commented Walters. "This is another development in the continued enhancement of our franchise and the firm's focus on mining companies as one of our primary sectors."
Prior to joining Max Capital, Brian was a mining research analyst with Research Capital and Scotia Capital where he published extensively on the mining industry and specialized in the uranium sector. Previous to equity research roles, Brian spent several years as a mining engineer working on large scale projects for Areva, Cameco and Thyssen Mining.
About Max Capital
Max Capital is a Toronto based investment banking boutique that provides capital raising and advisory services to late stage private firms and publicly traded companies. The firm has been active in leading small to mid-cap resource financings and specialized financings in Healthcare and Nanotechnology. The privately held firm now has offices in Toronto and London.
For more information, please click here
Max Capital Markets Ltd.
Copyright © Market WireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Leading Advanced Materials Manufacturer Pixelligent Closes $10.4 Million in Funding: Capital Will Boost Capacity for North American Manufacturing, Drive Asian Expansion, and Continue Innovation in Solid State Lighting and OLED Display Applications August 16th, 2016
Harris & Harris Group to Host a Shareholder Update Call, Including a Presentation by One of Its Precision Health and Medicine Portfolio Companies, Muses Labs, Inc., on August 23, 2016 August 16th, 2016
Nanosciences: Genes on the rack October 21st, 2016
Nanoparticle vaccinates mice against dengue fever October 21st, 2016